Product Information
DEPO-PROVERA 150 MG/ML SYRINGE is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $52.3282 per ML under NDC 00009737611. Its NADAC has been published 371 times since Apr 23, 2014.
FDA first approved this application on Oct 29, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the medroxyprogesterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009737611
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020246FDA Approved
10/29/1992
TE Code
AB
On Market Since
10/29/1992
Pharmacological Classes
Price Statistics
The NADAC for DEPO-PROVERA 150 MG/ML SYRINGE has been published 371 times since Apr 23, 2014, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $52.3282 per ML |
|---|---|
| All-time high | $193.2580 (Jan 16, 2019) |
| All-time low | $52.3282 (Jul 22, 2026) |
| 52-week high | $52.5371 |
| 52-week low | $52.3282 |
| Median price | $134.0259 |
| Average price | $121.3805 |
| Largest weekly change | -72.7% (Apr 17, 2024) |
| Weeks tracked | 371 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEPO-PROVERA 150 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for DEPO-PROVERA 150 MG/ML SYRINGE, manufactured by Pharmacia & Upjohn Company LLC, is $52.3282 per ML (NDC 00009737611), effective Aug 19, 2026.
How has the price of DEPO-PROVERA 150 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for DEPO-PROVERA 150 MG/ML SYRINGE has declined 54.0%. It has been tracked across 371 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for DEPO-PROVERA 150 MG/ML SYRINGE?
Since Apr 23, 2014, the NADAC for DEPO-PROVERA 150 MG/ML SYRINGE has ranged from a low of $52.3282 (Jul 22, 2026) to a high of $193.2580 (Jan 16, 2019), with a median of $134.0259 per ML.
Are there cheaper alternatives to DEPO-PROVERA 150 MG/ML SYRINGE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.3134 per ML — about 65% below DEPO-PROVERA 150 MG/ML SYRINGE.
Who manufactures DEPO-PROVERA 150 MG/ML SYRINGE?
DEPO-PROVERA 150 MG/ML SYRINGE (NDC 00009737611) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.